+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032- Product Image
Sale

Implantable Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6122548
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Implantable Contraceptive Drug Eluting Devices Market is projected to reach USD 508.52 Million in 2026. It is expected to continue growing at a CAGR of 5.54%, reaching USD 705.05 Million by 2032.

Implantable Contraceptive Drug-Eluting Devices: Executive Overview

Implantable contraceptive drug-eluting devices combine long-acting pregnancy prevention with localized or systemic drug delivery through an implanted platform. Their clinical value proposition centers on extended duration, reduced user adherence requirements, reversibility, and access to highly effective contraception. Market development is shaped by evidence on safety, efficacy, insertion and removal, patient counseling, reimbursement, regulatory requirements, and availability of trained providers. Because outcomes depend on both the device and the delivered drug, product evaluation requires an integrated view of pharmacology, materials, clinical practice, and health-system implementation.

Clinical, Regulatory, and Access Shifts Reshaping Adoption

The landscape is moving toward more patient-centered contraceptive care, with greater emphasis on informed choice, method reversibility, privacy, and continuity of use. Product developers and providers are also addressing insertion and removal experience, side-effect counseling, expulsion or migration risks where relevant, and compatibility with evolving clinical guidelines. Regulatory scrutiny increasingly focuses on biocompatibility, drug-release consistency, manufacturing controls, post-market surveillance, and evidence across diverse populations. Access is influenced by procurement systems, provider training, affordability, supply reliability, and the integration of long-acting contraception into primary care, reproductive-health, and postpartum services.

Artificial Intelligence Supports Discovery, Safety Monitoring, and Service Delivery

Artificial intelligence can contribute across the device lifecycle without replacing clinical validation or regulatory oversight. In research, machine-learning methods may help analyze drug-release profiles, materials performance, imaging, and patient-reported outcomes. In development and surveillance, structured data analysis can support identification of adverse-event patterns, protocol optimization, and quality-control investigations. In care delivery, decision-support tools may improve eligibility screening, counseling documentation, follow-up reminders, and identification of patients who need additional support. Responsible deployment requires representative data, explainability, privacy safeguards, cybersecurity, human review, and clear separation between algorithmic assistance and clinical decision-making.

Regional Insights: Access Conditions Differ Across Six Major Geographies

North America is characterized by established reproductive-health infrastructure, formal regulatory pathways, and strong interest in user-controlled long-acting methods, while affordability, insurance coverage, and provider availability remain important access variables. Latin America has substantial unmet need in some populations and may benefit from integration with public-sector family-planning programs, although procurement continuity and uneven service capacity can affect uptake. Europe combines mature clinical systems with stringent evidence and safety expectations; country-level reimbursement and guideline differences remain consequential. The Middle East and Africa present highly varied regulatory, cultural, and health-system conditions, making community engagement, respectful counseling, and reliable supply chains essential. Asia-Pacific includes advanced device and pharmaceutical capabilities alongside major differences in income, geography, regulation, and contraceptive access, favoring locally adapted delivery models.

Group Insights: Economic and Security Blocs Shape Policy and Procurement

ASEAN markets require approaches that account for diverse regulatory systems, health financing models, and urban-rural access gaps, with regional cooperation potentially supporting training and supply coordination. BRICS members span large and heterogeneous populations, so public-sector procurement, domestic manufacturing capability, and equitable distribution are important considerations. The European Union benefits from regulatory and policy coordination, but national reimbursement and service-delivery decisions still influence patient access. G7 countries generally have strong clinical infrastructure and evidence standards, while affordability, provider workload, and disparities among underserved groups remain relevant. GCC countries can leverage well-resourced health systems but may need tailored counseling and culturally responsive services. NATO members represent varied health systems, and continuity of reproductive care can be supported through resilient logistics, interoperability, and evidence-based national policy.

Country Insights: National Context Determines Implementation Priorities

Australia can emphasize integration with primary care and rural services; Brazil may benefit from strengthened public-sector access and provider training; Canada faces geographic and provincial variation that makes distribution and reimbursement coordination important. China has substantial clinical and manufacturing capabilities alongside complex regulatory and regional-access considerations. France, Germany, Italy, and Spain operate within a broader European evidence environment but retain distinct reimbursement, procurement, and service-delivery practices. India’s scale and diversity highlight the importance of affordability, public-health integration, and trained providers. Japan and South Korea require attention to mature regulatory systems, patient preferences, and demographic change. Mexico can prioritize continuity across public and private services and improved access beyond major urban centers. Russia’s implementation context is shaped by national regulation, health-system organization, and supply resilience. The United Kingdom must account for devolved health services, commissioning, and equitable access. The United States has advanced clinical infrastructure but significant variation in coverage, provider availability, and reproductive-health access across states and populations.

Action Priorities for Leaders: Build Evidence, Access, and Trust Together

Industry leaders should establish a lifecycle evidence plan covering clinical outcomes, reversibility, patient experience, drug-release consistency, adverse events, and real-world performance across relevant populations. Product design should prioritize ease of insertion and removal, predictable duration, biocompatibility, and clear counseling materials. Access strategies should align with public procurement, reimbursement requirements, provider-training capacity, and last-mile distribution rather than relying solely on demand generation. Partnerships with clinicians, public-health agencies, community organizations, and patient representatives can improve culturally appropriate implementation. Organizations should also invest in resilient manufacturing, traceable quality systems, privacy-preserving analytics, and transparent post-market surveillance. Any AI-enabled workflow should be validated prospectively, monitored for bias, and governed by accountable clinical and regulatory teams.

Research Methodology: Evidence-Based Synthesis of Device, Drug, and Health-System Factors

This executive summary uses a structured market-analysis framework focused on implantable contraceptive drug-eluting devices. The approach should triangulate peer-reviewed clinical and engineering literature, regulatory and safety documentation, clinical guidelines, public-health publications, procurement and reimbursement information, and credible health-system data. Analysis should distinguish established evidence from emerging hypotheses, assess findings by geography and population, and examine the interaction among device architecture, drug pharmacology, clinical workflow, patient preferences, and access conditions. Artificial-intelligence implications are considered by application area and governance requirement rather than treated as a standalone adoption assumption. The synthesis excludes unsupported market estimates, market shares, forecasts, and company-specific claims.

Conclusion: Durable Value Depends on Safe, Equitable, and User-Centered Delivery

Implantable contraceptive drug-eluting devices sit at the intersection of long-acting contraception, drug delivery, biomaterials, reproductive-health policy, and clinical service design. Their contribution will depend not only on technical performance, but also on informed choice, trustworthy safety evidence, trained providers, reliable supply, affordability, and respectful follow-up. Regional and national differences make implementation context critical, while artificial intelligence offers useful support for research, quality, surveillance, and care coordination when governed responsibly. Leaders that connect product innovation with equitable access and transparent evidence will be best positioned to translate device capabilities into meaningful reproductive-health outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Implantable Contraceptive Drug Eluting Devices Market, by Product Type
7.1. Introduction
7.2. Multi Rod
7.3. Single Rod
8. Implantable Contraceptive Drug Eluting Devices Market, by Drug Type
8.1. Introduction
8.2. Etonogestrel
8.3. Levonorgestrel
9. Implantable Contraceptive Drug Eluting Devices Market, by End User
9.1. Introduction
9.2. Clinics
9.2.1. Private Clinics
9.2.2. Public Clinics
9.3. Family Planning Centers
9.4. Hospitals
10. Implantable Contraceptive Drug Eluting Devices Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Implantable Contraceptive Drug Eluting Devices Market, by Polymer Material
11.1. Introduction
11.2. Biodegradable
11.3. Non-Biodegradable
12. Implantable Contraceptive Drug Eluting Devices Market, by Duration
12.1. Introduction
12.2. Five Year
12.3. Three Year
13. Implantable Contraceptive Drug Eluting Devices Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Implantable Contraceptive Drug Eluting Devices Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Implantable Contraceptive Drug Eluting Devices Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. 3Daughters, Inc.
17.2. AbbVie Inc.
17.3. Allergan, Inc.
17.4. Bayer AG
17.5. Boston Scientific Corporation
17.6. Celanese Corporation
17.7. Daré Bioscience, Inc.
17.8. DKT International
17.9. Femasys, Inc.
17.10. Gedeon Richter Plc.
17.11. Johnson & Johnson Services, Inc.
17.12. Lubrizol Life Science, Inc.
17.13. Medicines360
17.14. Medtronic plc
17.15. Mithra Pharmaceuticals SA
17.16. OCON Medical, Inc.
17.17. Organon & Co.
17.18. Pregna International Ltd.
17.19. Shanghai Dahua Pharmaceutical Co., Ltd.
17.20. The Cooper Companies, Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Implantable Contraceptive Drug Eluting Devices Market, Years Considered for the Study
FIGURE 2. Global Implantable Contraceptive Drug Eluting Devices Market, Research Design
FIGURE 3. Global Implantable Contraceptive Drug Eluting Devices Market, Research Framework
FIGURE 4. Global Implantable Contraceptive Drug Eluting Devices Market, Data Triangulation
FIGURE 5. Global Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2025 vs 2032 (%)
FIGURE 9. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2025 vs 2032 (%)
FIGURE 15. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2025 vs 2032 (%)
FIGURE 17. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Implantable Contraceptive Drug Eluting Devices Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Implantable Contraceptive Drug Eluting Devices Market Segmentation & Coverage
TABLE 2. Global Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 3. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Multi Rod Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Multi Rod Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Multi Rod Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Single Rod Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Single Rod Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Single Rod Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 11. Global Etonogestrel Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Etonogestrel Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Etonogestrel Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Levonorgestrel Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Levonorgestrel Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Levonorgestrel Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 18. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Private Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Private Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Private Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Public Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Public Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Public Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Family Planning Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Family Planning Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Family Planning Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 34. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 41. Global Biodegradable Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Biodegradable Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Biodegradable Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Non-Biodegradable Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Non-Biodegradable Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Non-Biodegradable Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 48. Global Five Year Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Five Year Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Five Year Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Three Year Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Three Year Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Three Year Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 63. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 65. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 66. North America Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 67. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 68. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 69. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 70. North America Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 71. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 73. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 74. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 76. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 78. Latin America Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 79. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 82. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 83. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 84. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 85. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 86. Europe Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 87. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 90. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 92. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 94. Middle East Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 95. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 98. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 100. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 102. Africa Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 103. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 107. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 109. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 110. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 111. ASEAN Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 112. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 114. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 115. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 117. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 118. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 119. GCC Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 120. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 122. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 123. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 125. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 126. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 127. European Union Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 128. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 130. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 131. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 132. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 133. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 134. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 135. BRICS Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 136. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 139. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 141. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 143. G7 Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 144. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 146. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 147. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 148. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 149. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 151. NATO Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 152. Global Implantable Contraceptive Drug Eluting Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. United States Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 154. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 155. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 156. United States Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 158. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 159. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 160. United States Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 161. Canada Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 162. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 164. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 166. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 167. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 168. Canada Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 169. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 170. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 171. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 172. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 174. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 176. Mexico Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 177. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 178. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 180. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 182. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 183. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 184. Brazil Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 185. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 186. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 190. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 191. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 192. United Kingdom Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 193. Germany Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 194. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 196. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 198. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 200. Germany Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 201. France Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 202. France Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. France Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 204. France Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. France Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 206. France Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. France Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 208. France Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 209. Russia Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 210. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 211. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 212. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 214. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 216. Russia Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 217. Italy Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 218. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 220. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 222. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 224. Italy Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 225. Spain Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 226. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 228. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 230. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 232. Spain Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 233. China Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 234. China Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 235. China Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 236. China Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. China Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 238. China Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 239. China Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 240. China Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 241. India Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 242. India Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 243. India Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 244. India Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. India Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 246. India Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 247. India Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 248. India Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 249. Japan Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 250. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 251. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 252. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 253. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 254. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 255. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 256. Japan Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 257. Australia Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 258. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 260. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 262. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 264. Australia Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 265. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, 2017-2032 (USD Million)
TABLE 266. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 267. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Drug Type, 2017-2032 (USD Million)
TABLE 268. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 270. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 271. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Polymer Material, 2017-2032 (USD Million)
TABLE 272. South Korea Implantable Contraceptive Drug Eluting Devices Market Size, by Duration, 2017-2032 (USD Million)
TABLE 273. Global Implantable Contraceptive Drug Eluting Devices Market Share, by Key Player, 2025
TABLE 274. Global Implantable Contraceptive Drug Eluting Devices Market, Key Experts

Companies Mentioned

  • 3Daughters, Inc.
  • AbbVie Inc.
  • Allergan, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Celanese Corporation
  • Daré Bioscience, Inc.
  • DKT International
  • Femasys, Inc.
  • Gedeon Richter Plc.
  • Johnson & Johnson Services, Inc.
  • Lubrizol Life Science, Inc.
  • Medicines360
  • Medtronic plc
  • Mithra Pharmaceuticals SA
  • OCON Medical, Inc.
  • Organon & Co.
  • Pregna International Ltd.
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • The Cooper Companies, Inc.

Related Topics

Related Reports

Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032 - Product Image

Contraceptive Drug Eluting Devices Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Intra-Uterine Contraceptive Devices Market Report 2026 - Product Image

Intra-Uterine Contraceptive Devices Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Drug Eluting Implants Market - Forecasts from 2025 to 2030 - Product Image

Drug Eluting Implants Market - Forecasts from 2025 to 2030

  • Report
  • 148 Pages
  • Global
From
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034? - Product Image

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034?

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.